Abstract
Key pointsWhat's already known about this topic? A disproportionate number of children with cyanotic heart disease suffer from neurodevelopmental (ND) impairment, which is believed to be due in part to abnormal cerebral development in utero. Magnetoencephelography (MEG) is a non‐invasive method for assessing neurodevelopment, but has not been studied in fetuses with congenital heart disease (CHD). What does this study add? In this preliminary study, we showed the feasibility of performing MEG in fetuses with CHD. Fetuses with CHD had different magnetoencephalographic characteristics when compared with matched controls.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
